Login to Your Account



FDA Signs Off On Namenda For Moderate To Severe Alzheimer's

By Aaron Lorenzo


Monday, October 20, 2003
Patients suffering from a seemingly hopeless affliction, and those around them, might gain a glimmer of hope on news of the FDA's approval of Namenda (memantine HCL) for Alzheimer's disease. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription